• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clozapine Toxicity in the Setting of COVID-19.

作者信息

Dotson Samuel, Hartvigsen Nathan, Wesner Tara, Carbary Timothy J, Fricchione Gregory, Freudenreich Oliver

机构信息

Department of Psychiatry, Massachusetts General Hospital, Boston, MA; Department of Psychiatry, Harvard Medical School, Boston, MA; Behavioral Health Team, Boston Hope COVID-19 Field Hospital, Boston, MA.

Department of Psychiatry, Massachusetts General Hospital, Boston, MA; Department of Psychiatry, Harvard Medical School, Boston, MA; Behavioral Health Team, Boston Hope COVID-19 Field Hospital, Boston, MA.

出版信息

Psychosomatics. 2020 Sep-Oct;61(5):577-578. doi: 10.1016/j.psym.2020.05.025. Epub 2020 May 30.

DOI:10.1016/j.psym.2020.05.025
PMID:32593477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7260496/
Abstract
摘要

相似文献

1
Clozapine Toxicity in the Setting of COVID-19.新型冠状病毒肺炎背景下的氯氮平毒性
Psychosomatics. 2020 Sep-Oct;61(5):577-578. doi: 10.1016/j.psym.2020.05.025. Epub 2020 May 30.
2
[Clozapine prescription in the wake of the coronavirus (SARS CoV-2) outbreak: What measures? Why?].[新型冠状病毒（SARS-CoV-2）疫情期间的氯氮平处方：采取哪些措施？原因何在？]
Encephale. 2020 Jun;46(3S):S123-S124. doi: 10.1016/j.encep.2020.04.001. Epub 2020 Apr 3.
3
Consensus statement on the use of clozapine during the COVID-19 pandemic.关于在2019冠状病毒病大流行期间使用氯氮平的共识声明。
J Psychiatry Neurosci. 2020 May 1;45(3):222-223. doi: 10.1503/jpn.200061.
4
[Thoughts on a favourable evolution of a COVID-19 in a patient with resistant schizophrenia and on a combination of clozapine and paliperidone palmitate].[关于一名耐药性精神分裂症患者COVID-19病情良好演变以及氯氮平与棕榈酸帕利哌酮联合使用的思考]
Encephale. 2020 Jun;46(3S):S126-S127. doi: 10.1016/j.encep.2020.05.009. Epub 2020 May 21.
5
Non-convulsive status epilepticus: COVID-19 or clozapine induced?非惊厥性癫痫持续状态：由新冠病毒感染还是氯氮平诱发？
BMJ Case Rep. 2020 Oct 4;13(10):e239015. doi: 10.1136/bcr-2020-239015.
6
COVID-19 infection causes a reduction in neutrophil counts in patients taking clozapine.COVID-19 感染可导致服用氯氮平的患者中性粒细胞计数减少。
J Psychiatry Neurosci. 2021 Mar 11;46(2):E232-E237. doi: 10.1503/jpn.200208.
7
Reactive Psychosis in a Health Care Worker During the COVID-19 Pandemic.新冠疫情期间一名医护人员的反应性精神病
Prim Care Companion CNS Disord. 2020 Jul 9;22(4):20l02692. doi: 10.4088/PCC.20l02692.
8
Command Suicidal Hallucination as Initial Presentation of Coronavirus Disease 2019 (COVID-19): A Case Report.以命令性自杀幻觉为首发表现的2019冠状病毒病（COVID-19）：一例报告
Psychosomatics. 2020 Sep-Oct;61(5):561-564. doi: 10.1016/j.psym.2020.05.022. Epub 2020 May 30.
9
COVID-19-associated brief psychotic disorder.新型冠状病毒肺炎相关的短暂性精神病性障碍
BMJ Case Rep. 2020 Aug 11;13(8):e236940. doi: 10.1136/bcr-2020-236940.
10
Neuroleptic malignant syndrome in a COVID-19 patient.一名新冠肺炎患者出现的抗精神病药恶性综合征
Brain Behav Immun. 2020 Aug;88:28-29. doi: 10.1016/j.bbi.2020.05.042. Epub 2020 May 18.

引用本文的文献

1
Prognostic Value of (rs2069514 and rs762551) Polymorphisms in COVID-19 Patients.COVID-19患者中（rs2069514和rs762551）多态性的预后价值
Balkan J Med Genet. 2023 Jul 31;26(1):35-42. doi: 10.2478/bjmg-2023-0005. eCollection 2023 Jul.
2
Exploring the Impact of COVID-19 Vaccination on Patients Taking Clozapine.探索新冠疫苗接种对服用氯氮平患者的影响。
Innov Clin Neurosci. 2023 Jan-Mar;20(1-3):32-38.
3
Clozapine Therapy and COVID-19: A Systematic Review of the Prevalence Rates, Health Outcomes, Hematological Markers, and Patient Perspectives.氯氮平治疗与 COVID-19：患病率、健康结局、血液学标志物及患者观点的系统评价。
Schizophr Bull. 2023 Jan 3;49(1):53-67. doi: 10.1093/schbul/sbac148.
4
Transient drop in the neutrophil count during COVID-19 regardless of clozapine treatment in patients with mental illness.患有精神疾病的患者在感染新冠病毒期间，无论是否接受氯氮平治疗，中性粒细胞计数都会出现短暂下降。
Rev Psiquiatr Salud Ment (Engl Ed). 2022 Apr-Jun;15(2):134-137. doi: 10.1016/j.rpsmen.2022.06.006.
5
Clozapine and Neutropenia in Patients with Schizophrenia and SARS-CoV-2 Infection.精神分裂症合并SARS-CoV-2感染患者中的氯氮平与中性粒细胞减少症
Neuropsychiatr Dis Treat. 2022 May 4;18:977-983. doi: 10.2147/NDT.S361405. eCollection 2022.
6
Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State-wide Psychiatric Hospital System.在纽约州一家精神科医院系统中，长期住院的严重精神疾病患者使用精神药物与 COVID-19 感染风险之间的关联。
JAMA Netw Open. 2022 May 2;5(5):e2210743. doi: 10.1001/jamanetworkopen.2022.10743.
7
Catatonia in older adults: A systematic review.老年人的紧张症：一项系统综述。
World J Psychiatry. 2022 Feb 19;12(2):348-367. doi: 10.5498/wjp.v12.i2.348.
8
Elevated Clozapine Blood Concentrations After Second COVID-19 Vaccination With Spikevax (COVID-19 Vaccine Moderna).第二次接种辉瑞新冠疫苗（COVID-19疫苗，Moderna）后氯氮平血药浓度升高
J Clin Psychopharmacol. 2022;42(3):317-320. doi: 10.1097/JCP.0000000000001522. Epub 2022 Jan 28.
9
Reduction in Absolute Neutrophil Counts in Patient on Clozapine Infected with COVID-19.氯氮平治疗的 COVID-19 感染患者的绝对中性粒细胞计数减少。
Int J Environ Res Public Health. 2021 Oct 27;18(21):11289. doi: 10.3390/ijerph182111289.
10
Clozapine treatment and risk of severe COVID-19 infection.氯氮平治疗与严重 COVID-19 感染风险。
Acta Psychiatr Scand. 2022 Jan;145(1):79-85. doi: 10.1111/acps.13379. Epub 2021 Oct 29.

本文引用的文献

1
Consensus statement on the use of clozapine during the COVID-19 pandemic.关于在2019冠状病毒病大流行期间使用氯氮平的共识声明。
J Psychiatry Neurosci. 2020 Apr 3;45(4):200061. doi: 10.1503/jpn.200061.
2
Elevated clozapine levels associated with infection: A systematic review.与感染相关的升高的氯氮平水平：系统评价。
Schizophr Res. 2018 Feb;192:50-56. doi: 10.1016/j.schres.2017.03.045. Epub 2017 Apr 6.
3
Clozapine: balancing safety with superior antipsychotic efficacy.氯氮平：平衡安全性与卓越的抗精神病疗效。
Clin Schizophr Relat Psychoses. 2012 Oct;6(3):134-44. doi: 10.3371/CSRP.6.3.5.
4
Clozapine withdrawal resulting in delirium with psychosis: a report of three cases.氯氮平戒断导致伴有精神病性症状的谵妄：三例报告
J Clin Psychiatry. 1997 Jun;58(6):252-5. doi: 10.4088/jcp.v58n0603.